Former FDA commissioner Margaret Hamburg to lead global dialogue on health systems and dementia

A global dialogue as part of the dementia landscape project series will gather international leaders to explore advances made and the challenges that remain for dementia and health systems.

We are pleased to announce this dialogue will be led by Dr Margaret Hamburg, an internationally recognized leader in public health and medicine and former Commissioner of the US Food and Drug Administration (FDA).

The global project is reviewing international progress towards the 2025 dementia goals. At the G8 dementia summit in 2013, governments pledged to work together to advance research, improve care, raise awareness and prevent dementia. We are currently holding a series of global dialogue events of global experts to inform this project, and in 2021 the Council will publish a report on progress towards the 2025 goals.

Other dialogues that have been held as part of this series have included the topics of research, which have explored biomarkers and advances in treatments as well as in clinical trialscare, which assessed the models of care and the burden of caregivers, as well as on prevention, which looked at the state of play around current thinking in risk reduction strategies and lessons from other public health initiatives. We have also held other further dialogue events on technology in dementia and dementia in low- and middle-income countries.